207 related articles for article (PubMed ID: 9624539)
41. Promises and failures of gallium as an antibacterial agent.
Minandri F; Bonchi C; Frangipani E; Imperi F; Visca P
Future Microbiol; 2014; 9(3):379-97. PubMed ID: 24762310
[TBL] [Abstract][Full Text] [Related]
42. Currently available antimicrobial agents and their potential for use as monotherapy.
Peterson LR
Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():30-45. PubMed ID: 19040464
[TBL] [Abstract][Full Text] [Related]
43. [Advances in the research of antibacterial properties of silver ion and its application in wound treatment].
Su XR; Xue YY; Li Q
Zhonghua Shao Shang Za Zhi; 2018 Mar; 34(3):183-186. PubMed ID: 29609281
[TBL] [Abstract][Full Text] [Related]
44. [The history of the development and changes of quinolone antibacterial agents].
Takahashi H; Hayakawa I; Akimoto T
Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
[TBL] [Abstract][Full Text] [Related]
45. Multidisciplinary approach to prostatitis.
Magri V; Boltri M; Cai T; Colombo R; Cuzzocrea S; De Visschere P; Giuberti R; Granatieri CM; Latino MA; Larganà G; Leli C; Maierna G; Marchese V; Massa E; Matteelli A; Montanari E; Morgia G; Naber KG; Papadouli V; Perletti G; Rekleiti N; Russo GI; Sensini A; Stamatiou K; Trinchieri A; Wagenlehner FME
Arch Ital Urol Androl; 2019 Jan; 90(4):227-248. PubMed ID: 30655633
[TBL] [Abstract][Full Text] [Related]
46. Mast cell activators as novel immune regulators.
Johnson-Weaver B; Choi HW; Abraham SN; Staats HF
Curr Opin Pharmacol; 2018 Aug; 41():89-95. PubMed ID: 29843056
[TBL] [Abstract][Full Text] [Related]
47. Antimicrobial Effects of Chemical Compounds Isolated from Traditional Chinese Herbal Medicine (TCHM) Against Drug-Resistant Bacteria: A Review Paper.
Zhao Y; Li H; Wei S; Zhou X; Xiao X
Mini Rev Med Chem; 2019; 19(2):125-137. PubMed ID: 30332952
[TBL] [Abstract][Full Text] [Related]
48. The treatment of infectious diseases: advances in the use of antimicrobial drugs.
HINSHAW HC
Calif Med; 1953 Oct; 79(4):282-3. PubMed ID: 13094538
[TBL] [Abstract][Full Text] [Related]
49. New antibacterial agents and their uses.
Lafong AC; Murphy PG
J Clin Hosp Pharm; 1986 Aug; 11(4):237-69. PubMed ID: 3531241
[No Abstract] [Full Text] [Related]
50. Novel Antibacterial Compounds and their Drug Targets - Successes and Challenges.
Kaczor AA; Polski A; Sobótka-Polska K; Pachuta-Stec A; Makarska-Bialokoz M; Pitucha M
Curr Med Chem; 2017; 24(18):1948-1982. PubMed ID: 27978802
[TBL] [Abstract][Full Text] [Related]
51. Enhancement of the effectiveness of antimicrobial therapy by muramyl peptide immunomodulators.
O'Reilly T; Zak O
Clin Infect Dis; 1992 May; 14(5):1100-9. PubMed ID: 1600012
[TBL] [Abstract][Full Text] [Related]
52. [Current antibacterial therapy in high-risk subjects].
Antimi M
Recenti Prog Med; 1982 Feb; 72(2):133-8. PubMed ID: 7100616
[No Abstract] [Full Text] [Related]
53. [The immunomodulatory and anti-inflammatory properties of different antimicrobial agents].
Guz K; Bugla-Płoskońska G
Postepy Hig Med Dosw (Online); 2007 Dec; 61():828-37. PubMed ID: 18097341
[TBL] [Abstract][Full Text] [Related]
54. Immunomodulation by macrolide antibiotics.
Labro MT; Abdelghaffar H
J Chemother; 2001 Feb; 13(1):3-8. PubMed ID: 11233797
[TBL] [Abstract][Full Text] [Related]
55. [Usefulness of PK/PD parameters of antimicrobials in the treatment of complex and extremely-resistant infections].
Horcajada JP
Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():16-8. PubMed ID: 26365728
[TBL] [Abstract][Full Text] [Related]
56. Models of In-Vivo Bacterial Infections for the Development of Antimicrobial Peptide-based Drugs.
Brunetti J; Falciani C; Bracci L; Pini A
Curr Top Med Chem; 2017; 17(5):613-619. PubMed ID: 27411321
[TBL] [Abstract][Full Text] [Related]
57. Antimicrobial Peptides and Innate Lung Defenses: Role in Infectious and Noninfectious Lung Diseases and Therapeutic Applications.
Hiemstra PS; Amatngalim GD; van der Does AM; Taube C
Chest; 2016 Feb; 149(2):545-551. PubMed ID: 26502035
[TBL] [Abstract][Full Text] [Related]
58. The tale of antibiotics beyond antimicrobials: Expanding horizons.
Yadav S; Shah D; Dalai P; Agrawal-Rajput R
Cytokine; 2023 Sep; 169():156285. PubMed ID: 37393846
[TBL] [Abstract][Full Text] [Related]
59. [Empiric antibacterial therapy of acute intestinal infections in children (manual for physicians)].
Gorelov AV; Maleev VV; Miliutina LN; Vorotyntseva NV; ;
Antibiot Khimioter; 2001; 46(10):19-24. PubMed ID: 11881189
[No Abstract] [Full Text] [Related]
60. Synergy among antibacterial peptides and between peptides and small-molecule antibiotics.
Cassone M; Otvos L
Expert Rev Anti Infect Ther; 2010 Jun; 8(6):703-16. PubMed ID: 20521897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
